Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Oct 22, 2022 4:55pm
107 Views
Post# 35041296

RE:RE:Joseph Arena Still Believes in TH

RE:RE:Joseph Arena Still Believes in THGive credit where credit is due.  I don't care how small the purchase, this is great news and good to see.  Who knows, maybe he will keep buying along with other insiders in the days ahead.  I've been lowering my cost basis and setting up the potential to take advantage of tax losses and also bought several thousand more shares over the last few days.  I found I can buy a couple hundred shares at a time when placing limit orders and if I try to buy at the low end of the bid/ask, the bid immediately rises to whatever my limit order is placed in.  I managed to buy 5,000 shares last week, but I had to do it in small traunches.  I probably could've placed a limit order and paid up $0.10/share, so I'm not willing to be critical of any share purchases.  Insiders should be smart with their buys as well.

Biobob wrote: Wow the key to cancer is worth 5k for our former Pfizer top executive... he beleives so much in Th1902 that he's putting 5k in Th... spitting in my face that's what he's doing.  I will tell you when we will have the POC answer.. when they exercise their options... if they keep them it works and if they sell it does'nt.. as simple as that.  It's human nature and we will have the answer loud and clear when that occurs... do you feel lucky punk....


<< Previous
Bullboard Posts
Next >>